MRI Based Bayesian Personalization of a Tumor Growth Model
IEEE Transactions on Medical Imaging
|May 11, 2016
Summary
This study introduces a Bayesian approach to personalize brain tumor growth models using magnetic resonance imaging. The method enhances understanding of patient-specific tumor parameters and their uncertainties, outperforming traditional techniques.
Area of Science:
- Mathematical biology
- Computational neuroscience
- Medical imaging analysis
Background:
- Mathematical modeling of brain tumor growth often uses reaction-diffusion models.
- Estimating model parameters is challenging due to identifiability issues, segmentation uncertainty, and model approximations.
Purpose of the Study:
- To analyze patient-specific parameter uncertainty in brain tumor growth models.
- To develop a more informative personalization approach using Bayesian inference.
Main Methods:
- Utilized a highly parallelized Lattice Boltzmann Method (LBM) for the reaction-diffusion equation.
- Employed Gaussian Process Hamiltonian Monte Carlo (GPHMC) for posterior probability estimation.
- Compared the Bayesian personalization with spherical asymptotic analysis and derivative-free optimization.
Main Results:
- The Bayesian personalization approach provided more informative results than traditional methods.
- It successfully sampled parameter posterior probabilities from patient-specific magnetic resonance images.
- Highlighted the presence of multiple modes and parameter correlations, which optimization methods missed.
Conclusions:
- Bayesian personalization offers a superior method for analyzing uncertainty in patient-specific tumor growth models.
- This approach yields richer insights into glioblastoma dynamics compared to existing techniques.
- The method demonstrates potential for improved clinical relevance in brain tumor research.
Related Concept Videos
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
Cancer Survival Analysis
819
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
819
Mouse Models of Cancer Study
6.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Mouse Models of Cancer Study
2.5K
2.5K


